Anti-obesity agent, pollakiuria improving agent, and autonomic nervous activity regulator
AssigneeAsahi Group Holdings, Ltd.
InventorsKohji Ohki, Koki Sato, Kazuhito Ohsawa
Life of this patent
Estimating the term…
Abstract
[Problem] The purpose of the present invention is to provide a novel technique associated with anti-obesity improvement. [Solution] The present invention relates to an anti-obesity agent comprising lactononadecapeptide (LNDP, Asn-Ile-Pro-Pro-Leu-Thr-Gln-Thr-Pro-Val-Val-Val-Pro-Pro-Phe-Leu-Gln-Pro-Glu) or a salt thereof. The present invention also relates to a pollakiuria improving agent and an autonomic nerve activity regulator each comprising LNDP.
Claims2
A method for improving pollakiuria, comprising administering a composition comprising an effective amount of a peptide consisting of the amino acid sequence of Asn-Ile-Pro-Pro-Leu-Thr-Gln-Thr-Pro-Val-Val-Val-Pro-Pro-Phe-Leu-Gln-Pro-Glu SEQ ID NO:
- 1 or a salt thereof to a patient-in need of improving pollakiuria.
Dependencies are inferred from the claim text.